2,129.00
-179.14
(-7.76%)
As of March 20 at 10:17:07 AM CST. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 5 | 12 | 12 |
Avg. Estimate | 3.03B | 3.2B | 12.04B | 12.91B |
Low Estimate | 2.99B | 3.17B | 11.99B | 12.61B |
High Estimate | 3.09B | 3.22B | 12.09B | 13.31B |
Year Ago Sales | 2.77B | 2.94B | 10.66B | 12.04B |
Sales Growth (year/est) | 9.43% | 8.65% | 12.92% | 7.20% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
BAH.MX | -- | -- | -- | -- |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
Maintains | Wells Fargo: Overweight to Overweight | 2/26/2025 |
Downgrade | William Blair: Outperform to Market Perform | 2/21/2025 |
Maintains | JP Morgan: Underweight to Underweight | 2/3/2025 |
Upgrade | Raymond James: Market Perform to Outperform | 2/3/2025 |
Maintains | TD Cowen: Buy to Buy | 1/8/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 1/8/2025 |